Paul J. Clancy
2011
In 2011, Paul J. Clancy earned a total compensation of $2.9M as EVP, Chief Financial Officer at Biogen, a 22% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $9,930 |
|---|---|
| Non-Equity Incentive Plan | $450,193 |
| Salary | $602,733 |
| Stock Awards | $1,799,250 |
| Other | $83,540 |
| Total | $2,945,646 |
Clancy received $1.8M in stock awards, accounting for 61% of the total pay in 2011.
Clancy also received $9.9K of change in pension value and nonqualified deferred compensation earnings, $450.2K in non-equity incentive plan, $602.7K in salary and $83.5K in other compensation.
Rankings
In 2011, Paul J. Clancy's compensation ranked 2,191st out of 10,747 executives tracked by ExecPay. In other words, Clancy earned more than 79.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,191 out of 10,747 | 80th |
Division Manufacturing | 784 out of 3,960 | 80th |
Major group Chemicals And Allied Products | 170 out of 1,033 | 84th |
Industry group Drugs | 99 out of 781 | 87th |
Industry Biological Products, Except Diagnostic Substances | 13 out of 157 | 92nd |
Source: SEC filing on April 30, 2014.
Clancy's colleagues
We found five more compensation records of executives who worked with Paul J. Clancy at Biogen in 2011.